Eos's antibody inhibits new blood vessel formation and was being researched as a treatment for solid tumors.

The antibodies developed by the human volunteers in the high-dose range not only neutralized the H.I.V. strain from which the vaccine was developed but also inhibited another strain of the virus.

We also observed that the antibodies raised against the IROMPs of A. baumannii also inhibited the binding of iron siderophore complex to purified OMPs.

Mr. Block said the antibodies will not cure AIDS, but can inhibit the virus's ability to enter immune cells, where they can multiply and go out of control.

In addition, these antibodies inhibit the activation of lower-affinity naive B cells that would be able to make more effective antibodies to the second virus.

If such is the case, the anti-idiotypic antibodies will be able to bind to the B lymphocyte receptor for the original antigen and inhibit the immune response to that antigen.

Monoclonal antibodies to ICAM-1 inhibited this IFN-γ enhanced ADCC activity.

These antibodies have been found to bind to the external domain of the glycoproteins and inhibit any other signaling to occur.

The anti-C1q antibodies found in patients with Hypocomplementaric Urticarian Vasculitis inhibit the activity of C1q.

The Phase I clinical trial has been completed that this antibody effectively inhibits the aggregation of human platelet with less hemorrhagic risk.